These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 21166898)
1. The structure of the catalytic domain of Tannerella forsythia karilysin reveals it is a bacterial xenologue of animal matrix metalloproteinases. Cerdà-Costa N; Guevara T; Karim AY; Ksiazek M; Nguyen KA; Arolas JL; Potempa J; Gomis-Rüth FX Mol Microbiol; 2011 Jan; 79(1):119-32. PubMed ID: 21166898 [TBL] [Abstract][Full Text] [Related]
2. Structure of the catalytic domain of the Tannerella forsythia matrix metallopeptidase karilysin in complex with a tetrapeptidic inhibitor. Guevara T; Ksiazek M; Skottrup PD; Cerdà-Costa N; Trillo-Muyo S; de Diego I; Riise E; Potempa J; Gomis-Rüth FX Acta Crystallogr Sect F Struct Biol Cryst Commun; 2013 May; 69(Pt 5):472-6. PubMed ID: 23695557 [TBL] [Abstract][Full Text] [Related]
3. A phage display selected 7-mer peptide inhibitor of the Tannerella forsythia metalloprotease-like enzyme Karilysin can be truncated to Ser-Trp-Phe-Pro. Skottrup PD; Sørensen G; Ksiazek M; Potempa J; Riise E PLoS One; 2012; 7(10):e48537. PubMed ID: 23119051 [TBL] [Abstract][Full Text] [Related]
5. Phage display selection of human single domain antibodies towards karilysin, a metalloproteinase and secreted virulence factor from Tannerella forsythia. Skottrup PD; Książek M; Potempa J J Immunol Methods; 2023 May; 516():113458. PubMed ID: 36921710 [TBL] [Abstract][Full Text] [Related]
6. A novel mechanism of latency in matrix metalloproteinases. López-Pelegrín M; Ksiazek M; Karim AY; Guevara T; Arolas JL; Potempa J; Gomis-Rüth FX J Biol Chem; 2015 Feb; 290(8):4728-4740. PubMed ID: 25555916 [TBL] [Abstract][Full Text] [Related]
7. A pathogenic trace of Tannerella forsythia - shedding of soluble fully active tumor necrosis factor α from the macrophage surface by karilysin. Bryzek D; Ksiazek M; Bielecka E; Karim AY; Potempa B; Staniec D; Koziel J; Potempa J Mol Oral Microbiol; 2014 Dec; 29(6):294-306. PubMed ID: 25175980 [TBL] [Abstract][Full Text] [Related]
8. Basis for substrate recognition and distinction by matrix metalloproteinases. Ratnikov BI; Cieplak P; Gramatikoff K; Pierce J; Eroshkin A; Igarashi Y; Kazanov M; Sun Q; Godzik A; Osterman A; Stec B; Strongin A; Smith JW Proc Natl Acad Sci U S A; 2014 Oct; 111(40):E4148-55. PubMed ID: 25246591 [TBL] [Abstract][Full Text] [Related]
9. Bioinformatic comparison of structures and homology-models of matrix metalloproteinases. Andreini C; Banci L; Bertini I; Luchinat C; Rosato A J Proteome Res; 2004; 3(1):21-31. PubMed ID: 14998159 [TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinases: fold and function of their catalytic domains. Tallant C; Marrero A; Gomis-Rüth FX Biochim Biophys Acta; 2010 Jan; 1803(1):20-8. PubMed ID: 19374923 [TBL] [Abstract][Full Text] [Related]
11. Substrate specificity determinants of human macrophage elastase (MMP-12) based on the 1.1 A crystal structure. Lang R; Kocourek A; Braun M; Tschesche H; Huber R; Bode W; Maskos K J Mol Biol; 2001 Sep; 312(4):731-42. PubMed ID: 11575928 [TBL] [Abstract][Full Text] [Related]
12. An IgY-based immunoassay to evaluate the biomarker potential of the Tannerella forsythia virulence factor karilysin in human saliva. Skottrup PD; López R; Ksiazek M; Højrup P; Baelum V; Potempa J; Kaczmarek JZ J Immunol Methods; 2019 Jun; 469():26-32. PubMed ID: 30880264 [TBL] [Abstract][Full Text] [Related]
13. Structural studies on MMPs and TIMPs. Bode W; Maskos K Methods Mol Biol; 2001; 151():45-77. PubMed ID: 11217319 [No Abstract] [Full Text] [Related]
14. Crystal structures of MMPs in complex with physiological and pharmacological inhibitors. Maskos K Biochimie; 2005; 87(3-4):249-63. PubMed ID: 15781312 [TBL] [Abstract][Full Text] [Related]
15. A metalloproteinase karilysin present in the majority of Tannerella forsythia isolates inhibits all pathways of the complement system. Jusko M; Potempa J; Karim AY; Ksiazek M; Riesbeck K; Garred P; Eick S; Blom AM J Immunol; 2012 Mar; 188(5):2338-49. PubMed ID: 22287711 [TBL] [Abstract][Full Text] [Related]
16. Structural basis of matrix metalloproteinases and tissue inhibitors of metalloproteinases. Maskos K; Bode W Mol Biotechnol; 2003 Nov; 25(3):241-66. PubMed ID: 14668538 [TBL] [Abstract][Full Text] [Related]
17. Computational insights into the selectivity mechanism of APP-IP over matrix metalloproteinases. Geng L; Gao J; Cui W; Tang Y; Ji M; Chen B J Comput Aided Mol Des; 2012 Dec; 26(12):1327-42. PubMed ID: 23224743 [TBL] [Abstract][Full Text] [Related]
19. The intermediate S1' pocket of the endometase/matrilysin-2 active site revealed by enzyme inhibition kinetic studies, protein sequence analyses, and homology modeling. Park HI; Jin Y; Hurst DR; Monroe CA; Lee S; Schwartz MA; Sang QX J Biol Chem; 2003 Dec; 278(51):51646-53. PubMed ID: 14532275 [TBL] [Abstract][Full Text] [Related]
20. Active site specificity profiling of the matrix metalloproteinase family: Proteomic identification of 4300 cleavage sites by nine MMPs explored with structural and synthetic peptide cleavage analyses. Eckhard U; Huesgen PF; Schilling O; Bellac CL; Butler GS; Cox JH; Dufour A; Goebeler V; Kappelhoff R; Keller UAD; Klein T; Lange PF; Marino G; Morrison CJ; Prudova A; Rodriguez D; Starr AE; Wang Y; Overall CM Matrix Biol; 2016 Jan; 49():37-60. PubMed ID: 26407638 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]